Wednesday, 4 February 2015

Alembic Pharma Q3 PAT at Rs70.6 crore

Total Income has increased from Rs. 4858.50 million for the quarter ended December 31, 2013 to Rs. 5119.10 million for the quarter ended December 31, 2014. 

Alembic Pharmaceuticals Ltd has posted a net profit after tax and share of profit of associates of Rs. 706.60 million for the quarter ended December 31, 2014 as compared to Rs. 659.30 million for the quarter ended December 31, 2013.

 Total Income has increased from Rs. 4858.50 million for the quarter ended December 31, 2013 to Rs. 5119.10 million for the quarter ended December 31, 2014.

No comments:

Post a Comment